Drug recall · December 17, 2025
Varenicline Tablets recall
Why: Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 43598-908-56
- Lots / codes
Lot # F2400244, Exp Date: 10/31/2026
- Quantity
- 4800 54-count bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Distributed Nationwide
- Initiated
- November 11, 2025 · Voluntary: Firm initiated
- Classified
- December 5, 2025
- Reported
- December 17, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Varenicline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.